TOCQUEVILLE ASSET MANAGEMENT L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 155 filers reported holding SAGE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$208,000
-97.0%
2,875
-94.2%
0.00%
-96.8%
Q3 2019$6,996,000
-38.1%
49,865
-19.2%
0.10%
-34.9%
Q2 2019$11,305,000
+13.7%
61,745
-1.2%
0.15%
+9.8%
Q1 2019$9,945,000
+26.8%
62,525
-23.6%
0.13%
+12.7%
Q4 2018$7,844,000
-35.8%
81,885
-5.3%
0.12%
-23.4%
Q3 2018$12,211,000
-19.8%
86,450
-11.1%
0.15%
-20.2%
Q2 2018$15,230,000
+67.8%
97,295
+72.6%
0.19%
+66.4%
Q1 2018$9,077,000
+47.7%
56,355
+51.1%
0.12%
+65.7%
Q4 2017$6,144,000
+67.5%
37,300
-36.7%
0.07%
+66.7%
Q3 2017$3,669,000
-35.5%
58,900
-17.6%
0.04%
-38.2%
Q2 2017$5,690,000
+31.1%
71,450
+17.0%
0.07%
+28.3%
Q1 2017$4,339,000
+34.8%
61,050
-3.2%
0.05%
+29.3%
Q4 2016$3,219,000
+57.6%
63,050
+42.1%
0.04%
+64.0%
Q3 2016$2,043,000
-14.2%
44,375
-43.9%
0.02%
+66.7%
Q2 2016$2,382,000
+88.0%
79,050
+100.0%
0.02%
-11.8%
Q1 2016$1,267,000
-44.1%
39,525
+1.7%
0.02%
-45.2%
Q4 2015$2,266,000
+61.7%
38,875
+17.4%
0.03%
+63.2%
Q3 2015$1,401,000
-15.4%
33,100
+45.8%
0.02%
-5.0%
Q2 2015$1,657,000
+101.3%
22,700
+38.6%
0.02%
+100.0%
Q1 2015$823,00016,3750.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders